清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis

医学 双氯芬酸 骨关节炎 依托三酯 对乙酰氨基酚 荟萃分析 罗非昔布 麻醉 随机对照试验 安慰剂 内科学 临床试验 类阿片 替代医学 化学 酶 受体 环氧合酶 病理 生物化学
作者
Bruno R. da Costa,Tiago Pereira,Pakeezah Saadat,Martina Rudnicki,Samir Iskander,Nicolas S. Bodmer,Pavlos Bobos,Li Gao,Henry Dan Kiyomoto,Thaís Montezuma,Matheus Oliveira de Almeida,Pai-Shan Cheng,Cesar A. Hincapié,Roman Hari,Alex J. Sutton,Peter Tugwell,GILLIAN A. HAWKER,Peter Jüni
出处
期刊: [BMJ]
卷期号:375: n2321-n2321 被引量:416
标识
DOI:10.1136/bmj.n2321
摘要

OBJECTIVE: To assess the effectiveness and safety of different preparations and doses of non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and paracetamol for knee and hip osteoarthritis pain and physical function to enable effective and safe use of these drugs at their lowest possible dose. DESIGN: Systematic review and network meta-analysis of randomised trials. DATA SOURCES: Cochrane Central Register of Controlled Trials (CENTRAL), Medline, Embase, regulatory agency websites, and ClinicalTrials.gov from inception to 28 June 2021. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Randomised trials published in English with ≥100 patients per group that evaluated NSAIDs, opioids, or paracetamol (acetaminophen) to treat osteoarthritis. OUTCOMES AND MEASURES: The prespecified primary outcome was pain. Physical function and safety outcomes were also assessed. REVIEW METHODS: Two reviewers independently extracted outcomes data and evaluated the risk of bias of included trials. Bayesian random effects models were used for network meta-analysis of all analyses. Effect estimates are comparisons between active treatments and oral placebo. RESULTS: 192 trials comprising 102 829 participants examined 90 different active preparations or doses (68 for NSAIDs, 19 for opioids, and three for paracetamol). Five oral preparations (diclofenac 150 mg/day, etoricoxib 60 and 90 mg/day, and rofecoxib 25 and 50 mg/day) had ≥99% probability of more pronounced treatment effects than the minimal clinically relevant reduction in pain. Topical diclofenac (70-81 and 140-160 mg/day) had ≥92.3% probability, and all opioids had ≤53% probability of more pronounced treatment effects than the minimal clinically relevant reduction in pain. 18.5%, 0%, and 83.3% of the oral NSAIDs, topical NSAIDs, and opioids, respectively, had an increased risk of dropouts due to adverse events. 29.8%, 0%, and 89.5% of oral NSAIDs, topical NSAIDs, and opioids, respectively, had an increased risk of any adverse event. Oxymorphone 80 mg/day had the highest risk of dropouts due to adverse events (51%) and any adverse event (88%). CONCLUSIONS: Etoricoxib 60 mg/day and diclofenac 150 mg/day seem to be the most effective oral NSAIDs for pain and function in patients with osteoarthritis. However, these treatments are probably not appropriate for patients with comorbidities or for long term use because of the slight increase in the risk of adverse events. Additionally, an increased risk of dropping out due to adverse events was found for diclofenac 150 mg/day. Topical diclofenac 70-81 mg/day seems to be effective and generally safer because of reduced systemic exposure and lower dose, and should be considered as first line pharmacological treatment for knee osteoarthritis. The clinical benefit of opioid treatment, regardless of preparation or dose, does not outweigh the harm it might cause in patients with osteoarthritis. SYSTEMATIC REVIEW REGISTRATION: PROSPERO number CRD42020213656.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
机智的如曼完成签到,获得积分10
3秒前
Xzx1995完成签到 ,获得积分10
5秒前
FashionBoy的应助被科研通管家采纳,获得10
8秒前
fairytaler的应助被科研通管家采纳,获得10
8秒前
现代的初之完成签到,获得积分10
14秒前
大模型的应助被蜗牛好好飞采纳,获得10
15秒前
ChatGPT完成签到,获得积分10
17秒前
慕青的应助被蜗牛好好飞采纳,获得10
21秒前
夏同学完成签到 ,获得积分10
22秒前
今后的应助被蜗牛好好飞采纳,获得10
27秒前
wwrjj完成签到,获得积分0
28秒前
搜集达人的应助被cc采纳,获得10
29秒前
大模型的应助被蜗牛好好飞采纳,获得10
32秒前
38秒前
38秒前
御坂10576号完成签到,获得积分10
38秒前
40秒前
义气的雅琴完成签到,获得积分10
41秒前
cc发布了新的文献求助10
43秒前
NexusExplorer的应助被蜗牛好好飞采纳,获得10
44秒前
Harlotte完成签到 ,获得积分0
45秒前
蒋不惜完成签到,获得积分10
51秒前
changfox完成签到,获得积分10
51秒前
hyk完成签到 ,获得积分10
51秒前
milalala完成签到 ,获得积分10
1分钟前
浚稚完成签到 ,获得积分10
1分钟前
1分钟前
冷傲的夜白完成签到,获得积分10
1分钟前
岳晓燕完成签到 ,获得积分10
1分钟前
1分钟前
清脆代真发布了新的文献求助50
1分钟前
1分钟前
谭访冬完成签到,获得积分10
1分钟前
MUAN完成签到 ,获得积分10
1分钟前
1分钟前
细腻海瑶完成签到,获得积分10
1分钟前
铁瓜李完成签到 ,获得积分10
1分钟前
1分钟前
红烧肉耶完成签到 ,获得积分10
1分钟前
小小菜完成签到 ,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173230
求助须知:如何正确求助?哪些是违规求助? 9565593
关于积分的说明 21780525
捐赠科研通 7767429
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555764
邀请新用户注册赠送积分活动 2476697